Generic Carvedilol

Buy Generic Carvedilol () without prescription in Canada

Carvedilol (3.125 mg, 6.25 mg, 12.5 mg, 25 mg): Comprehensive Patient Information for Canada

Basic Product Information

Mechanism of Action

In simple terms: Carvedilol is a beta-blocker that also has alpha-blocking effects. It slows your heart rate, reduces the force of heart contractions, and widens blood vessels. This lowers blood pressure and reduces the workload on your heart, helping it pump more efficiently. Carvedilol is especially helpful in heart failure because it blocks the harmful effects of stress hormones on the heart over the long term.

For specialists: Carvedilol is a third-generation, non-selective beta-adrenergic and alpha-1 adrenergic receptor blocker. It is a racemic mixture of two enantiomers: S(-)-carvedilol, which possesses non-selective beta-blocking activity, and R(+)-carvedilol, which has alpha-1 blocking properties. Both enantiomers exhibit alpha-adrenergic blocking properties. Carvedilol suppresses the renin-angiotensin-aldosterone system through beta-blockade, reducing renin release, and induces vasodilation via selective alpha-1 receptor blockade, thereby reducing peripheral vascular resistance. At high concentrations, carvedilol also has weak to moderate calcium channel-blocking activity. It also demonstrates antioxidant properties. Carvedilol has no intrinsic sympathomimetic activity.

Pharmacokinetics

• Absorption: Carvedilol is rapidly absorbed after oral administration, with peak plasma concentrations (Cmax) reached in approximately 1 to 1.5 hours. The absolute oral bioavailability is approximately 25% in healthy subjects due to extensive first-pass metabolism in the liver. Taking carvedilol with food slows the rate of absorption and reduces the incidence of orthostatic effects.
• Metabolism: Carvedilol is extensively metabolized in the liver via oxidation and conjugation, primarily by CYP2D6 and CYP2C9, with minor contributions from other CYP enzymes. Three active metabolites with beta-blocking activity have been identified; the 4'-hydroxyphenyl metabolite is approximately 13 times more potent than carvedilol for beta-blockade. Two hydroxycarbazole metabolites are extremely potent antioxidants, 30 to 80 times more potent than carvedilol.
• Elimination: Carvedilol is eliminated primarily via biliary excretion, with less than 2% of the dose excreted unchanged in the urine. The mean elimination half-life is approximately 6 hours. Plasma clearance is approximately 500–700 mL/min.
• Distribution: Carvedilol is highly lipophilic, with approximately 95% plasma protein binding. The volume of distribution ranges from 1.5 to 2 L/kg and is increased in patients with liver cirrhosis.

Uses in Daily Life and Best Practice Advice

Carvedilol is prescribed in Canada for the management of heart failure and other cardiovascular conditions. Your physician will determine the appropriate dose and titration schedule based on your specific condition and response to treatment.

• Typical Uses: Mild to severe chronic heart failure of ischemic or non-ischemic origin; left ventricular dysfunction following myocardial infarction; essential hypertension (alone or with other antihypertensives).
• Administration: Tablets are taken orally twice daily with food. Take at the same times each day. Do not crush or chew.
• Titration: Carvedilol must be started at a low dose and gradually increased over weeks under close medical supervision. The dose is not increased until symptoms of heart failure or vasodilation have stabilized.
• Monitoring: Your physician will monitor your heart rate, blood pressure, kidney function, and symptoms, especially during dose adjustments. Report any weight gain, increased shortness of breath, or swelling promptly.
• Do Not Stop Suddenly: Abrupt discontinuation can worsen angina or precipitate a heart attack. Do not stop taking carvedilol without consulting your physician.

Morning vs. Evening Dosing

Carvedilol is typically taken twice daily, approximately 12 hours apart. There is no specific clinical recommendation for morning versus evening dosing, but taking it with breakfast and dinner helps with consistency and absorption. Always follow the schedule recommended by your physician.

• Morning and Evening: Taking doses approximately 12 hours apart helps maintain steady levels of the medication in your blood.
• Consistency: Take carvedilol at the same times every day to ensure maximum effectiveness.
• Missed Dose: If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not take two doses at the same time.
• Professional Guidance: Your healthcare provider may adjust the timing based on your other medications and daily routine.

Administration With or Without Food

Carvedilol should be taken with food to slow the rate of absorption and reduce the incidence of orthostatic effects (dizziness upon standing). Taking it with a meal also helps improve absorption consistency.

• Take carvedilol with a meal or snack, such as breakfast and dinner.
• Swallow the tablet whole with a full glass of water.
• Do not crush, chew, or split the tablet unless directed by your pharmacist or physician.
• Avoid taking on an empty stomach to minimize the risk of dizziness and low blood pressure.

Interaction Warnings

Indications for Carvedilol

* "Off-label" means use outside the official approved indication, usually based on current medical guidelines and scientific evidence.

Dosing According to Clinical Indication

Doses should always be adjusted according to the advice of your physician and depending on your health condition and tolerability. Fluid retention should be minimized before starting carvedilol. If bradycardia (heart rate

Side Effects and Safety Profile

Guidelines for Correct Use

• Take carvedilol exactly as prescribed by your physician. Do not change your dose without medical advice.
• Take the tablets with food, at the same times each day, approximately 12 hours apart.
• Swallow tablets whole with water. Do not crush, chew, or split unless directed by your pharmacist.
• Do not stop taking carvedilol suddenly, as this can worsen your condition. If you need to discontinue, your physician will taper the dose gradually.
• Keep all medical appointments for monitoring of heart rate, blood pressure, and kidney function.
• Inform every healthcare provider (including dentists, surgeons, and pharmacists) that you are taking carvedilol.
• Weigh yourself daily and report sudden weight gain or increased swelling to your physician.
• Avoid driving or hazardous activities until you know how carvedilol affects you, especially when starting treatment or increasing the dose.
• If you are pregnant, planning to become pregnant, or breastfeeding, consult your physician. Carvedilol should not be used during pregnancy or breastfeeding unless clearly needed.
• If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double the dose.

Alternative Treatment Options

• Bisoprolol: A cardioselective beta-1 blocker commonly used in heart failure. Available in Canada and covered by most provincial drug plans. Does not have alpha-blocking properties.
• Metoprolol succinate (extended-release): A beta-1 selective blocker with evidence for mortality reduction in heart failure. Taken once daily. Available in Canada.
• Nebivolol: A third-generation beta-1 selective blocker with vasodilating properties via nitric oxide enhancement. May have fewer sexual side effects than carvedilol.
• Labetalol: A combined alpha- and beta-blocker used primarily for hypertension, including in pregnancy. Less commonly used for heart failure.
• Ivabradine: A selective sinus node inhibitor that lowers heart rate without reducing contractility. May be an alternative for patients who cannot tolerate beta-blockers.

Comparison: Carvedilol is distinguished from other beta-blockers by its combined alpha-1 and non-selective beta-blocking activity, which provides additional vasodilation and may be particularly beneficial in heart failure. It has demonstrated mortality benefit in major heart failure trials. However, its twice-daily dosing and higher incidence of dizziness compared with cardioselective agents such as bisoprolol may affect tolerability. Your physician will determine the best beta-blocker for your specific condition and health status.

Legal Status, Registration, and Coverage in Canada

• Registration: Carvedilol is authorized for sale in Canada by Health Canada as a prescription drug. It is available in multiple generic formulations from various manufacturers.
• Prescription Status: Prescription only in Canada.
• Coverage: Provincial drug plan coverage varies. Carvedilol coverage is not a benefit in Ontario or British Columbia under certain programs. Bisoprolol and spironolactone have more universal coverage. Private insurance plans typically cover carvedilol. Generic formulations are more affordable than the brand-name Coreg.
• Pharmacovigilance: Adverse reactions should be reported to Health Canada's MedEffect Canada program.

Recent Research and Clinical Guidelines (2022–2026)

• The 2025 Canadian Cardiovascular Society (CCS) guideline update for heart failure management continues to recommend carvedilol as one of the preferred beta-blockers for heart failure with reduced ejection fraction (HFrEF), with a starting dose of 3.125 mg twice daily and a target dose of 25 mg twice daily (or 50 mg twice daily for patients >85 kg).
• The CECCY trial (final results published in 2026) evaluated carvedilol for the prevention of chemotherapy-induced cardiotoxicity. The study provided further data on the cardioprotective role of carvedilol in patients receiving anthracycline-based chemotherapy.
• The DICE study (2026) is investigating the combination of carvedilol and empagliflozin in patients with cirrhosis and diastolic dysfunction, exploring potential benefits in this complex patient population.
• Model-informed dose optimization research (2026) has explored carvedilol dosing in cirrhotic patients, suggesting that dose reductions may be appropriate in this population due to altered pharmacokinetics.
• The CARFLECT IV trial is comparing carvedilol versus flecainide for idiopathic ventricular extrasystoles and tachycardia, evaluating their efficacy in reducing ventricular arrhythmias.

Availability and Supply in Canada

Prices and availability may vary by province, territory, and pharmacy. Generic carvedilol products are available from multiple manufacturers and are generally more affordable than the brand-name Coreg. Some formulations may be subject to supply shortages; check with your local pharmacy for current availability. DOM-Carvedilol and RAN-Carvedilol have been listed as cancelled post-market in Canada as of 2025. TEVA-Carvedilol experienced a supply shortage starting in December 2025 that was subsequently resolved and discontinued.

Frequently Asked Questions (FAQ)

1. What is the difference between the different tablet strengths of carvedilol?
   The different strengths (3.125 mg, 6.25 mg, 12.5 mg, and 25 mg) allow for gradual dose titration. Your physician will start you on a low dose (usually 3.125 mg twice daily for heart failure) and increase it slowly over weeks to reach the target dose that is right for you. Never adjust your dose without medical advice.
2. Why must I take carvedilol with food?
   Taking carvedilol with food slows the rate of absorption and reduces the chance of dizziness and lightheadedness that can occur when the drug is absorbed too quickly. It also helps ensure consistent absorption from dose to dose.
3. Can I stop taking carvedilol if I feel better?
   No. Do not stop taking carvedilol without consulting your physician. Stopping suddenly can worsen angina, precipitate a heart attack, or cause your heart failure symptoms to return. Your physician will taper the dose gradually if discontinuation is necessary.
4. What should I do if I miss a dose of carvedilol?
   If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take your next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.
5. Will carvedilol interact with my other medications?
   Carvedilol can interact with several medications, including cimetidine, rifampicin, amiodarone, fluoxetine, paroxetine, digoxin, insulin, oral antidiabetics, and calcium channel blockers. Always inform your physician and pharmacist about all medications and supplements you are taking.
6. Can I drink grapefruit juice while taking carvedilol?
   No. Grapefruit and grapefruit juice can increase the levels of carvedilol in your blood and cause unpredictable side effects. Avoid them during treatment.
7. Is carvedilol safe during pregnancy?
   Carvedilol should not be used during pregnancy or breastfeeding unless clearly needed and prescribed by your physician. Consult your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding.
8. What are the signs of worsening heart failure I should watch for?
   Report sudden weight gain (more than 2–3 pounds in a day or 5 pounds in a week), increased shortness of breath, swelling of your feet, ankles, or legs, or increased fatigue to your physician promptly. These may indicate fluid retention and may require a diuretic dose adjustment.